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Abstract
Background: Haematopoiesis is a process of formation of mature blood cells from hematopoietic progenitors in bone 
marrow. Haematopoietic progenitors are stimulated by growth factors and cytokines to proliferate and differentiate, 
and they die via apoptosis when these factors are depleted. An aberrant response to growth environment may lead to 
haematological disorders. Bomapin (serpinb10) is a hematopoietic- and myeloid leukaemia-specific protease inhibitor 
with unknown function.
Results: We found that the majority of naturally expressed bomapin was located in the nucleus. Both the natural and 
recombinant bomapin had a disulfide bond which linked the only two bomapin cysteines: one located in the CD-loop 
and the other near the C-terminus. Computer modelling showed that the cysteines are distant in the reduced 
bomapin, but can easily be disulfide-linked without distortion of the overall bomapin structure. Low-level ectopic 
expression of bomapin in bomapin-deficient K562 cells resulted in about 90% increased cell proliferation under normal 
growth conditions. On the other hand, antisense-downregulation of natural bomapin in U937 cells resulted in a 
decreased cell proliferation. Bomapin C395S mutant, representing the reduced form of the serpin, had no effect on cell 
proliferation, suggesting that the disulfide bond-linked conformation of bomapin is biologically important. The 
bomapin-dependent effect was specific for myeloid cells, since ectopic expression of the serpin in HT1080 cells did not 
change cell proliferation. In contrast to the survival-promoting activity of bomapin in cells cultured under optimal 
growth conditions, bomapin enhanced cell apoptosis following growth factor withdrawal.
Conclusions: We propose that bomapin is a redox-sensitive nuclear serpin that augments proliferation or apoptosis of 
leukaemia cells, depending on growth factors availability.
Background
Mature blood cells arise in bone marrow from a small
population of haematopoietic stem cells during the hae-
matopoietic process. Haematopoietic stem cells give rise
to erythroid/myeloid and lymphoid precursors which
then continuously proliferate and differentiate to adult
blood cells [1]. Biological functions of haematopoietic
cells are tightly regulated with multiple growth factors
and cytokines, and by interactions with other cells in
bone marrow compartment. These factors determine the
rate of haematopoietic cells renewal, proliferation, differ-
entiation, and apoptosis. A failure to respond to external
stimuli regulating these processes within bone marrow
micro-environment may lead to haematological disorders
[2,3].
The serpins (serine protease inhibitors) form a protein
superfamily, with members identified in all organisms [4].
Although designated as protease inhibitors, serpins have
also other functions that are not related to their inhibi-
tory activity. All serpins have a common tertiary struc-
ture with a dominant β-sheet A supporting a mobile
reactive centre loop (RCL) [5]. The P1-P1' peptide bond
in the RCL acts as a bait for target proteases. Serpins
inhibit their target proteases by a mechanism that
involves cleavage of the RCL and its insertion into β-sheet
A, with simultaneous translocation of the covalently-
bound protease to the opposite pole of the serpin mole-
cule [6-10]. The serpins that have been studied most
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extensively are extracellular proteins. They control pro-
teases in various patho-physiological processes, including
inflammation, coagulation, and angiogenesis [4,11].
The human genome encodes 35 serpins, which are
grouped into nine clades (A-I). The clade B includes 13
intracellular serpins [12]. Some of them are cross-class
inhibitors, inhibiting both serine and cysteine proteases
[13]. Eight of them have a unique inter-helical loop, the
so-called CD-loop [12], which is an important functional
domain of the serpins [4]. Although the clade B serpins
are thought to regulate apoptosis or cell differentiation,
their targets remain mostly unknown.
Bomapin (serpinb10) belongs to the clade B of human
serpins. It is expressed only in bone marrow, leukocytes
of patients with myeloid leukaemia that correspond to
myeloid progenitors [14], and promyelocytic leukaemia
cell lines (HL60, THP1, and AML-193), but it is not pres-
ent in terminally differentiated leukocytes [15]. This pro-
tein has a 22 amino acid-long CD-loop that contains a
nuclear localization signal [16,17]. Bomapin is assumed
to have P1-Arg at its reactive centre which is consistent
with  in vitro inhibition of thrombin and trypsin [14].
Bomapin complex with a possible intracellular protease
was detected in HeLa cells over-expressing the serpin, but
the protease was not identified [17]. It was proposed that
bomapin possibly regulates a protease in the early stages
of hematopoietic differentiation [15]. However, the roles
of bomapin and its intracellular partners still remain
unknown.
The main focus of the present studies is to determine
the biological role of the haematopoietic-specific
bomapin. We show that naturally expressed human
bomapin is located in the nucleus, where it exists in an
oxidized form with a single disulfide bond. We show also
that bomapin has the capacity to influence the fate of
myeloid progenitors/leukaemia cells by enhancing their
proliferation under optimal growth conditions, or by sen-
sitizing them to apoptosis when the growth conditions
are improper. This function of bomapin may be of partic-
ular importance because a tight regulation of cell prolifer-
ation and apoptosis, and balance between the two
processes, are critical for normal haematopoietic process
and for preventing haematological diseases.
Results
Bomapin has reactive cysteines that form intramolecular 
disulfide bond
Bomapin was expressed in a thioredoxin reductase defi-
cient E. coli strain, and purified by sequential metal-affin-
ity and ion-exchange chromatography. From the ion-
exchange column, bomapin eluted in two partially over-
lapping peaks; the first peak contained bomapin mono-
mer, whereas the second peak contained mainly bomapin
dimer (Figure 1A, lanes 1 and 4) and small amount of
Figure 1 Conformation of the recombinant and naturally ex-
pressed bomapin is redox-dependent. (A) Purified recombinant bo-
mapin analyzed by SDS-PAGE followed by Coomassie blue staining: 
lanes 1 and 4, non-reduced bomapin eluted from ion-exchange col-
umn in peak 1 and peak 2 (respectively); lanes 2 and 5, DTT-reduced 
bomapin from peak 1 and peak 2 (respectively); lanes 3 and 6, non-re-
duced bomapin from peak 1 and peak 2 (respectively) incubated with 
a 4-fold molar excess of trypsin and then analyzed under reducing con-
ditions. (B) Indirect chromogenic assay to detect inhibitory activity of 
bomapin. Trypsin alone or trypsin pre-incubated with different 
amounts of bomapin (at bomapin/trypsin molar ratios as indicated) 
was mixed with S-2288 chromogenic substrate, and residual trypsin 
activity was measured at 405 nm in 1 min time intervals. (C) Immuno-
localization of naturally expressed bomapin in THP1 cells. The cells 
were stained with rabbit anti-bomapin antibodies followed by Alexa-
Fluor 568-labeled secondary antibody; DNA was stained with DAPI. (D) 
Bomapin was immunoprecipitated from HL60 cell extract and ana-
lyzed by SDS-PAGE followed by western blot: lane 1, non-reduced bo-
mapin; lane 2, DTT-reduced bomapin. (E) In silico homology models of 
bomapin in its reduced and oxidized forms. The central β-sheet A is 
shown in blue, the reactive centre loop in red, the CD-loop in yellow, 
and the two cysteine residues in green.Przygodzka et al. BMC Cell Biology 2010, 11:30
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higher order oligomers (data not shown). Interestingly,
the purified monomeric bomapin migrated on non-
reducing SDS-PAGE as a strong 40-kDa band, and as a
weak 45-kDa band (Figure 1A, lane 1). However, only the
45-kDa band was present under reducing conditions
(lane 2). This difference in electrophoretic mobility sug-
gests that the only two bomapin cysteines, C68 (located
in the middle of the CD-loop) and C395 (located close to
the C-terminus), form an intramolecular disulfide bond.
The oxidized and reduced monomeric forms of bomapin,
as well as oligomeric species of the protein, were active as
inhibitors since they formed an SDS-stable complex with
trypsin (Figure 1A, lane 3 and 6). As shown by an indirect
chromogenic assay, bomapin was able to inhibit about
90% of trypsin activity at bomapin/trypsin 0.87 molar
ratio, and at 1.74 ratio all trypsin was inhibited (Figure
1B). This data suggest that bomapin forms 1:1 complex
with trypsin, and support the general model for 1:1 com-
plex formation between serpin and protease [4].
Immunostaining of bomapin in THP1 cells (Figure 1C)
and HL-60 cells (data not shown) revealed that naturally
expressed bomapin is mainly localized in the nucleus.
Since nuclear proteins can be stabilized by disulfide
bonds [18,19], the redox status of the nuclear bomapin
became of particular interest. Thus, bomapin was immu-
noprecipitated from HL60 cells and analyzed by 7% SDS-
PAGE followed by western blot. The electrophoretic
migration of the naturally expressed bomapin (Figure 1D)
resembled that of the recombinant protein, suggesting
that majority of natural bomapin exists in the oxidized
form which contains the intramolecular C68-C395 disul-
fide bond. In contrast to E. coli-expressed bomapin, we
have not detected disulfide-linked dimers for the natu-
rally-expressed bomapin.
To provide a structural reference for the redox forms of
bomapin, models of the reduced and oxidized forms of
bomapin were constructed using homology modelling
and simulated annealing calculations (Figure 1E). In the
model of reduced bomapin, cysteines C68 and C395 are
separated by a distance of about 30 Å, they are surface-
exposed and likely to take part in redox reactions. The
entire CD-loop (residues 62 to 86) is located on the side
of the bomapin molecule. Secondary structure predic-
tions using APSSP2 server http://www.imtech.res.in/
raghava/apssp2/ predicts random coils structure from
Asn 62 to Glu 72 and between Leu 83 to Ser 86, and a
helical tendency between Ser 73 and Asn 82. Thus, the
CD-loop can be predicted to be flexible, and it can there-
fore easily be translocated so that the C68-C395 disulfide
bond can be introduced without apparent perturbation of
the overall structure of bomapin.
Wild-type bomapin promotes proliferation of myeloid 
progenitor cells
To investigate the role of bomapin, we stably transfected
K562 cells with bomapin-EGFP fusion or EGFP alone. As
shown in Figure 2A, bomapin-EGFP was localized in the
nucleus whereas the control EGFP was distributed in
both the nucleus and cytoplasm. The expression level of
bomapin-EGFP in K562 cells, measured by bomapin-spe-
cific ELISA, was similar to that of native bomapin in
THP-1, U937 and HL-60 cells (Table 1).
Proliferation of the bomapin-EGFP and EGFP express-
ing cells was assayed by manual counting, and by using
cell proliferation reagent WST1. As shown in Figure 2B,
bomapin-EGFP cells had about 90% higher cell density at
96 h of incubation than those expressing EGFP. Prolifera-
tion of wild-type (wt) K562 cells, although slightly higher
than for EGFP cells, was still significantly lower than for
bomapin-EGFP cells. Bomapin-EGFP cells metabolized
the WST1 reagent faster than the EGFP cells (Figure 2C).
Finally, the nuclei of bomapin-EGFP cells were about 50%
larger than the nuclei of EGFP cells (Figure 2D). Doubling
time during the linear phase of cell growth was shorter
for bomapin-EGFP cells (25.8 ± 0.6 h) than for EGFP cells
(35.6 ± 3.0 h) and wt K562 cells (29.5 ± 2.5 h). However, as
shown by DNA-flow cytometry analyses, the cell distri-
bution in the G0/G1, S, and G2/M phases for bomapin-
EGFP cells (43.9, 32.5, and 19.9%, respectively) was simi-
lar to that for EGFP cells (41.7, 32.2, and 21.5%, respec-
tively), suggesting that bomapin had no effect on
distribution of cells during the cell cycle. In addition, the
difference in percentage of trypan blue-positive cells for
exponentially growing bomapin-EGFP cells (2.4 ± 0.2%)
and the control EGFP cells (2.9 ± 0.3%) was not statisti-
cally significant, suggesting that the increased prolifera-
tion of bomapin-EGFP cells can not be explain by a lower
apoptosis rate.
To show that native bomapin also has en effect on cell
proliferation, we incubated U937 cells with bomapin-spe-
cific antisense (BAS3) or sense (BS) DNA oligonucle-
otides. Proliferation of all oligonucleotide-treated cells
was lower than proliferation of untreated U937 cells,
which can possibly result from the known slightly toxic
effect of the nucleotides on cells. Nevertheless, the anti-
sense-treated cells had decreased bomapin levels (Figure
2E), and had about 40% lower cell proliferation (Figure
2F), compared to the cells incubated with the sense oligo-
nucleotide. In addition, U937 cells incubated with BAS3
metabolized less WST-1 reagent than the control U937
cells incubated with BS (data not shown).
To find out whether bomapin can influence prolifera-
tion of other cells, not only myeloid progenitors, wePrzygodzka et al. BMC Cell Biology 2010, 11:30
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expressed bomapin in HT-1080 cells. In these cells,
bomapin-EGFP was also located in the nucleus (data not
shown), and was expressed to a similar level as it was in
leukaemia cells (Table 1), but it had no effect on cell pro-
liferation (Figure 2G).
Bomapin mutant lacking disulfide bond has no effect on 
cell proliferation
As majority of natural bomapin was found in the confor-
mation where the CD-loop was linked to C-terminal part
of the protein via a disulfide bond, it was of interest
whether the oxidized form of bomapin is important for
the observed bomapin effect on cell proliferation. There-
fore, we created a single-cysteine bomapin mutant
(C395S) lacking the disulfide bond, which represents the
reduced form of bomapin. Expressed in E. coli, this
mutant was active as inhibitor and formed an SDS-stable
complex with trypsin (Figure 3A). The C395S-bomapin-
EGFP fusion expressed in K562 cells had nuclear localiza-
tion (Figure 3B), as it was shown for wt bomapin (Figure
2A). Expression level of the C395S mutant in K562 cells
was also similar to the wild type bomapin (Table 1). How-
ever, proliferation of the cells that were expressing the
C395S-bomapin-EGFP mutant was identical to that of
the control cells expressing EGFP (Figure 3C). This
strongly suggests that it is the oxidized form of bomapin
that is important for the enhancement of cell prolifera-
tion.
Figure 2 Wt bomapin promotes proliferation of stably-transfected multi-clonal K562 cells. (A) Cellular localization of bomapin-EGFP and EGFP 
in transfected K562 cells. (B) Proliferation of the K562 cells expressing bomapin-EGFP and EGFP, and the wt K562 cells (seeded at 2 × 104 cell/ml) mea-
sured by manual cell counting. The data represent a mean of three independent experiments, each counted in triplicate. (C) Proliferation of the stably 
transfected K562 cells measured with the WST-1 reagent. (D) Size of nuclei in K562 cells expressing bomapin-EGFP and EGFP. The symbol "..." indicates 
statistical significance with p < 0.0001 by unpaired t-test. (E) U937 cells were incubated with bomapin-specific antisense (BAS3) and sense (BS) phos-
phorothioated DNA oligonucleotides (20 nmol/ml); at different time points bomapin was immunoprecipitated with IgY immobilized on NHS-Sephar-
ose and detected with western blot. Western blot of residual amounts of IgY detached from the beads during immunoprecipitation is shown as 
loading control. (F) U937 cells were seeded at a density of 1 × 104 cells/ml in the absence or the presence of the antisense BAS3 and corresponding 
sense BS oligonucleotides, and proliferation was measured by manual counting. The data represent the means of three independent experiments, 
each counted in triplicate. (G) Proliferation of the HT-1080 cells expressing bomapin-EGFP and EGFP (seeded at 2 × 104 cell/ml) measured by manual 
cell counting. The data represent a mean of three independent experiments.Przygodzka et al. BMC Cell Biology 2010, 11:30
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Bomapin enhances cell apoptosis following withdrawal of 
growth factors
Haematopoietic progenitors deprived of growth factors
undergo mitogenic arrest that is followed by apoptosis
[20]. Therefore, we tested whether the haematopoietic-
specific bomapin has an effect on cell apoptosis. For this
purpose, we incubated K562 cells expressing bomapin-
EGFP, wt K562 cells, and K562 cells expressing EGFP,
under normal growth conditions or in the absence of
serum. At different time points of the starvation, dead
cells were labelled with trypan blue and counted under
microscope. As shown in Figure 4A, the amount of dead
cells was about 65-70% higher for bomapin-EGFP cells,
than for the parental K562 cells and EGFP cells. The cells
were also stained with annexin V-PE-Cys5 and then
apoptotic cells showing purple fluorescence on cell mem-
brane were counted under microscope (Figure 4B).
Again, there was about 100% more apoptotic cells in the
cells expressing bomapin-EGFP than in the control cells.
T h e  a n a l y s i s  o f  c e l l  c y c l e  p h a s e s  o f  E G F P - e x p r e s s i n g
K562 cells cultured without serum showed a progressive
increase of cell population in G2/M-phase with a con-
comitant decrease of cell population in S-phase, com-
pared to the cell distribution under normal growth
conditions. Under the same conditions, bomapin-EGFP
expression resulted in accumulation of cells in S-phase,
while the cell number in G2/M-phase remained constant
(Figure 4C).
Apoptosis is characterized by cleavage of several intrac-
ellular proteins. Therefore, the cell extracts from EGFP-
and bomapin-EGFP-expressing cells were analyzed for
two apoptotic markers: lamins-A/C and PARP. There was
no, or very little, degradation of lamins-A/C and cleavage
of PARP in all the cells under normal growth condition
(Figure 4D, lanes 1). However, bomapin-EGFP cells
revealed more pronounced degradation of lamins-A/C
and higher cleavage of PARP following serum starvation,
than the control wt K562 and EGFP-expressing cells (Fig-
ure 4D, lanes 2). The data indicate that bomapin expres-
sion facilitates apoptosis of K562 cells following
withdrawal of growth factors.
Discussion
Haematopoiesis is the best studied stem cell differentia-
tion process, where hematopoietic progenitors self-renew
and differentiate into blood cells, or undergo apoptosis.
Any failure to respond to stimuli regulating these pro-
cesses may lead to leukaemia. Many transcription factors
that regulate the haematopoietic processes have been
described. However, the downstream pathways, including
regulation of various factors by proteases - and control of
the latter by specific inhibitors - are less well defined. In
Table 1: Expression levels of natural and recombinant 
bomapin in cells
Cell line Bomapin (ng bomapin/mg 
total protein)
HL-60 0.55 ± 0.02
U937 1.85 ± 0.29
THP-1 2.44 ± 0.58
K562 expressing bomapin-
EGFP
1.29 ± 0.26
K562 expressing C395S 
bomapin-EGFP
1.23 ± 0.21
HT1080 expressing bomapin-
EGFP
2.58 ± 0.32
Exponentially growing cells were lysed in a lysis buffer containing 
protease inhibitor cocktail, and bomapin level was quantified by 
bomapin-specific ELISA (as described in Methods section).
Figure 3 C395S bomapin mutant, representing reduced form of 
bomapin, does not enhance proliferation of K562 cells. (A) SDS-
PAGE analysis (followed by Coomassie blue staining) of the E. coli ex-
pressed and purified recombinant C395S bomapin mutant (lane 1) and 
the mutant protein incubated with a 4-fold molar excess of trypsin 
(lane 2). (B) Cellular localization of C395S-bomapin-EGFP in stably 
transfected K562 cells. (C) Proliferation of the stably transfected multi-
clonal K562 cells expressing bomapin-EGFP, C395S-bomapin-EGFP, 
and EGFP alone, as measured by manual cell counting. Higher prolifer-
ation of K562 cells expressing wt bomapin, compared to Fig. 2B, is due 
to higher generation number of the cells that were used in this exper-
iment.Przygodzka et al. BMC Cell Biology 2010, 11:30
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this study , we have used leukaemia cells as a model of
myeloid progenitor cells. We have shown that the hae-
matopoietic-specific bomapin (serpinb10) is a nuclear,
redox-sensitive protein that enhances proliferation of
myeloid leukaemia cells under normal growth conditions,
and enhances apoptosis of the cells following growth fac-
tors withdrawal.
Bomapin has two cysteines: C68 which is located in the
long CD-loop, and C395 located close to the C-terminus.
Molecular modelling of bomapin suggests that these
cysteines in the reduced form of bomapin are distant, sol-
vent-exposed and predicted to be highly reactive. Due to
a high potential flexibility/mobility of the CD-loop, the
cysteines can be disulfide-linked to form intramolecular
disulfide bond without major perturbations of the
bomapin structure (Figure 1E). The high reactivity of
both cysteines is supported by the fact that bomapin
expressed in E. coli was present in the form of oxidized
monomer (having the two cysteines connected by disul-
fide bond), and disulfide-linked dimers (Figure 1A). SDS-
PAGE analysis of immunoprecipitated naturally
expressed bomapin showed that majority of the protein
existed in the oxidized monomeric form with intramolec-
ular disulfide bond (Figure 1D). There is a theoretical
possibility that bomapin was artificially oxidized during
immunoprecipitation and SDS-PAGE, however, the fact
that disulfide-linked conformation of bomapin is impor-
tant for an enhanced cell proliferation (Figure 3C)
strongly suggests that the oxidized monomers of
bomapin existed already in intact cells. In contrast to the
bacterial-expressed bomapin, we have not observed any
oligomeric species for the naturally expressed bomapin in
leukaemia cells. This could be due to low bomapin levels
(Table 1) and crowding effect in nucleus, or known differ-
ences in redox environment between nucleus of human
cells and bacterial cytoplasm.
Although it is generally known that cytosolic compart-
m e n t  o f  e u ka ry o t i c  c e l l s  h as  a  h i gh  r ed u ci n g  po t e n t ia l
which prevents the formation of stable disulfide bonds in
proteins, relatively less is known about redox potential of
nuclear compartment. However, several reports show
that nuclear proteins may exist in oxidized forms with
disulfide bonds of functional importance. For example,
lamins-A/C, which are structural proteins of nuclear
envelope, have to be in the form of disulfide-stabilized
dimer to be able to bind chromatin DNA [18]; formation
of a single intramolecular disulfide bond in transcription
factor Yap1 is responsible for redistribution of the protein
into nucleus [19]; disulfide-linked form of clusterin is
known to accumulate in nuclei of early apoptotic epithe-
lial cells [21]. Therefore, the existence of a disulfide bond
in naturally expressed bomapin is consistent with its
nuclear localization (Figure 1C). The disulfide bond also
appears to be essential for the function of bomapin since
only wt/oxidized bomapin, but not the C395S mutant,
was capable of enhancing proliferation of K562 cells (Fig-
ure 3C). These data suggest that the oxidised conforma-
tion of bomapin is important for an interaction of the
serpin with another nuclear protein, and that bomapin
effect on cell proliferation might be dependent only on
the redox status of bomapin. However, with the current
knowledge, we can not exclude a scenario where bomapin
inhibitory activity is also involved, but it becomes essen-
tial only after the oxidized bomapin binds to its nuclear
partner. Bomapin is a second, after its closest homologue
plasminogen activator inhibitor type 2 (PAI-2, serpinb2),
redox-dependent intracellular serpin. For PAI-2, the for-
Figure 4 Bomapin enhances cell apoptosis following growth fac-
tors withdrawal. K562 cells and the cells expressing bomapin-EGFP or 
EGFP were incubated in the presence or the absence of serum in the 
media. At different time points, cells were mixed with trypan blue and 
dead cells were quantified by manual counting (A), or the cells were in-
cubated with annexin-PE-Cys5, and annexin-labelled cells were quan-
tified under fluorescence microscope with excitation and emission 
wavelengths 488 nm and 670 nm, respectively (B); (C) Progression of 
cell cycle in bomapin-EGFP and EGFP-expressing K562 cells following 
serum withdrawal. Percentage of G0/G1, S, and G2/M phases were cal-
culated by deconvolution of DNA content histograms; ns - insignifi-
cant; ".." indicates statistical significance with p < 0.05. (D) K562 cells 
expressing bomapin-EGFP or EGFP were incubated in serum-contain-
ing media (lanes 1) or in media without serum (lanes 2) for 48 h. Then, 
cell extracts were analyzed by western blot with monoclonal antibod-
ies against lamins-A/C and rabbit antibodies against cleaved PARP as 
apoptotic markers. Western blot for β-actin in the same gel is shown as 
loading control.Przygodzka et al. BMC Cell Biology 2010, 11:30
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mation of a single disulfide bond between cysteines
located in the CD-loop and at the bottom of the serpin
molecule, induces conformational changes which result
in spontaneous non-covalent polymerization of the ser-
pin [22,23], but biological function of the conformational
switch is unknown.
To study intracellular function of bomapin, we took
advantage of the fact that the human K562 cells do not
express bomapin naturally (real-time PCR and immuno-
precipitation, data not shown; [15]), and stably trans-
fected the cells with bomapin-EGFP fusion, or EGFP as a
control. Consistent with previous studies on HeLa cells
over-expressing GFP-bomapin [16], the bomapin-EGFP
fusion in K562 cells had a dominant nuclear distribution
(Figure 2A). Expression of bomapin-EGFP in K562 cells
resulted in about 90% higher cell proliferation (Figure 2B
and 2C), and a significant shortening of the cell cycle
without changes in distribution of cells in different
phases of cell cycle. Bomapin-EGFP expressing cells had
also bigger nuclei than the control cells (Figure 2D). On
the other hand, down regulation of bomapin expression
in U937 cells by means of antisense oligonucleotides
resulted in a decreased cell proliferation (Figure 2F), sug-
gesting that the bomapin effect on cell proliferation was
not specific for the K562 cells only. However, the effect of
bomapin on cell proliferation was leukaemia/hae-
matopoietic-specific because expression of bomapin-
EGFP in the human fibrosarcoma HT1080 cells did not
change proliferation of the cells (Figure 2G). This strongly
suggests that bomapin needs a haematopoietic-specific
partner protein to enhance cell proliferation. Two other
serpins from clade B have been reported to influence cell
proliferation. The first one is rat trespin which is believed
to be a homolog of human bomapin, but it is expressed in
various tissues whereas bomapin is bone marrow-specific
[15,24]; over-expression of trespin in human embryonic
kidney epithelial cell line (Hek293) resulted in an
increased proliferation of the cells [24]. The second one is
kidney-specific mouse megsin which is responsible for
increased proliferation of messangial cells in megsin-
transgenic mice [25]. The mechanism(s) behind serpin-
dependent enhancement of cell proliferation remains yet
unknown.
Bone marrow haematopoietic progenitors, quiescent
without stimulation, can be activated to proliferate and to
differentiate by cytokines and growth factors. When
growth factor levels decrease, the cells undergo mitotic
arrest followed by apoptosis that leads to termination of
cell expansion [3,20,26]. In contrast, leukemic cells cul-
tured in the absence of growth factors can continue to
proliferate and evade apoptosis for a long time. In the
case of K562 cells, the aberrant Bcr/Abl fusion kinase
activates both proliferation and anti-apoptotic signals
that are responsible for relatively high proliferation rate
of these cells, and their resistance to apoptosis [27]. How-
ever, bomapin-EGFP expressing K562 cells cultured with-
out serum showed an increased cell accumulation in S-
phase and increased apoptosis, compared to the control
cells expressing EGFP (Figure 4). Therefore, bomapin
antagonise the anti-apoptotic properties of Bcr/Abl
fusion and sensitizes K562 cells to apoptosis when
growth factors are absent.
Conclusions
Hematopoiesis requires a tight balance between prolifer-
ation and apoptosis of hematopoietic progenitors. This
balance is controlled by many factors, including cytokines
and growth factors. Although precise signalling pathways
and downstream effectors balancing proliferation and
apoptosis are not fully known, they may involve AKT,
E2F1/Rb protein, and/or Myc signalling pathways [28].
These signalling pathways respond to growth factor levels
by inducing cell proliferation or cell apoptosis. Here we
show that bomapin, a nuclear and redox-sensitive pro-
tein, can stimulate proliferation of myeloid progenitor
cells under normal growth condition, and can increase
apoptosis of the cells following the growth factors
removal. We therefore propose that bomapin is involved
in a pathway that sensitizes myeloid progenitor cells to
growth environment. Since proper regulation of cellular
proliferation and apoptosis is essential for normal
hematopoiesis and for prevention of leukemic transfor-
mation, the function of bomapin described here may be
of considerable importance.
Methods
Expression and purification of bomapin from E. coli
The  BamH1 and  Xho1  restriction sites in the pET15b
vector (Novagen) were flipped using Quick Change Site-
Directed Mutagenesis Kit (Stratagene) and primers: 5'-
CTGGTGCCGCGCGGCAGCGGATCCCTCCTCGAG
CCGGCTGCTAACAAAGCCCG-3' and 5'-CGGGCT
TTGTTAGCAGCCGGCTCGAGGAGGGATCCGCTG
CCGCGCGGCACCAG-3'. Bomapin cDNA was excised
from the PGEX-4T-1-bomapin vector (a kind gift from
Dr. R Schleef [14]) using Xho1 and BamH1, and cloned to
the "flipped" pET15b vector. The C395S mutation was
introduced with primers: 5'-CTTTTTTATGGAAGAT-
TATCCTCC CCCTAA-3' and 5'-TTAGGGGGAGGA-
TAATCTTCCATAAAAAAG-3', and followed by full-
length cDNA sequencing. E. coli AD494(DE3) (Novagen)
was then transformed and induced with 0.1 mM IPTG
(isopropyl-β-D-thiogalactoside) to produce histidine-
tagged bomapin. Bomapin was purified under native con-
ditions on a TALON column (Clontech Laboratories)
according to the manufacturer's instructions. Then, it
was desalted on a NAP-25 column, loaded onto a MonoQ
HR 5/5 column (both GE Healthcare), and eluted withPrzygodzka et al. BMC Cell Biology 2010, 11:30
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NaCl gradient in 20 mM HEPES, pH 7.0. The yields of
purification of wt bomapin and the C395S mutant were
1.2 mg and 0.13 mg per 1 L of bacterial culture, respec-
tively.
Assay for inhibitory activity of bomapin
The inhibitory activity of bomapin against bovine trypsin
(Sigma) was measured by a chromogenic assay using the
substrate S-2488 (Chromogenics). Bomapin and trypsin
were diluted in activity assay buffer (0.05 M Tris/HCl, pH
7.5, containing 0.15 M NaCl and 0.05% Tween 80) to final
concentrations 15 μg/ml and 10 μg/ml, respectively.
Trypsin (10 μl) was mixed in a 96-well plate with various
amounts of bomapin to obtain bomapin/trypsin molar
ratios 0.87, 1.74, and 4.3 (in total volume 100 μl), and
incubated for 5 min at room temperature. Then 100 μl of
0.4 mM S-2488 substrate was added and absorbance at
405 nm was measured at 1 min intervals in a Titertek
Multiscan spectrophotometer.
Cell culture
We have used leukaemia cell lines originating from differ-
ent subclasses of myeloid leukaemia. However, the com-
mon characteristic of these cells is that their
differentiation is blocked at early stages of myeloid differ-
entiation: the HL-60 (acute promyelocytic leukaemia)
and K562 (chronic myelogenous leukaemia) cells repre-
sent multipotent myeloid progenitors, and U937 (histio-
cytic lymphoma) and THP-1 (acute monocytic
leukaemia) cells represent monocytic progenitors. The
K562 cells (naturally bomapin-deficient), as well as U937,
HL60, and THP1 cells (all expressing bomapin) were cul-
tured in RPMI-1640 medium. The human fibrosarcoma
HT-1080 cells (bomapin-deficient) were cultured in
DMEM medium. All media were substituted with 10%
foetal bovine serum (FBS), 2 mM L-glutamine, strepto-
mycin (100 μg/ml), and penicillin (100 U/ml) (all from
Gibco BRL). All the cells were from ECACC.
Expression of bomapin in eukaryotic cells and proliferation 
assays
Bomapin cDNA was amplified from the PGEX-4T-1-
bomapin vector by PCR using pfu-DNA polymerase and
primers 5'-AAAGCTGAATTCTCGAGGCACCATG-
GACTCTCTAGCAACATCAATC-3' and 5'-GGCGA
CCGGATCCGCGGGGGAGCATAATCTTCCATAAA
A-3' containing XhoI and BamH1 cleavage sites (respec-
tively). The PCR product was cloned into pd2EGFP-N1
vector (Clontech) using the above restriction sites, and
fully sequenced. The C395S mutation was introduced
with primers: 5'-CTTTTTTATGGAAGATTATCCTC-
CCCCTAA-3' and 5'-TTAGGGGGAGGATAATCTTC-
CATAAAA AAG-3', and followed by full-length cDNA
sequencing. The pd2EGFP-N1 vector encodes for a
destabilized bomapin-EGFP fusion protein with a half-
life of about 2 h. K562 cells were transfected using lipo-
fectamine 2000 (Life Technologies), selected with Geneti-
cin (0.6 mg/ml, Life Technologies), and sorted with a
fluorescence-activated cell sorter (Becton Dickinson). To
correct for clone variation, all experiments were per-
formed on a multiclonal pool of the stably transfected
cells. Proliferation of K562 cells expressing wt bomapin
was increasing with increasing cell generation number,
whereas proliferation of K562 expressing the C395S
bomapin mutant was decreasing with higher generation
number. Cell proliferation was assayed by manual count-
ing of trypan blue-excluded cells, and with Cell Prolifera-
tion Reagent WST-1 (4-[3-(4-Iodophenyl)-2-(4-
nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate;
Roche).
Apoptosis assays
Apoptosis in K562 cells and the K562 cells stably express-
ing EGFP or bomapin-EGFP was induced by serum star-
vation. At different time points, the amount of dead cells
was quantified by manual cell counting in the presence of
trypan blue. For detection of apoptotic cells, 1 × 105 cells
in 20 mM Hepes pH 7.1, supplemented with 0.14 M NaCl
and 25 mM CaCl2, were incubated with annexin V-PE-
Cys5 (Abcam) according to manufacturer's instruction,
and cell-surface annexin-labelled cells were counted
under fluorescent microscope (with excitation and emis-
sion wavelengths 488 nm and 670 nm, respectively); non-
labelled cells were counted under normal phase light. In
addition, cell extracts at different times of serum starva-
tion were prepared in 10 mM Tris/HCl, pH 7.5 with 0.1
M NaCl, 1 mM EDTA 1% Triton X-100, and protease
inhibitor cocktail (Roche Diagnostic), and analysed by
western blot with antibodies for two apoptotic markers:
lamins-A/C (rabbit antibodies against C-terminal frag-
ment of Lamin A; Biolegend) and cleaved PARP (rabbit
antibodies specific for cleaved PARP; Abcam), and for β-
actin (with monoclonal antibodies to human β-actin;
Sigma) as loading control.
Flow cytometry
For cell-cycle analyses, cells were fixed in 70% ethanol,
treated with RNase A (500 μg/ml), and stained with pro-
pidium iodide (10 μg/ml). Cell cycle analysis was per-
formed on a flow cytometer (Cytomix FC500; Backman
Coulter).
Antibodies against bomapin and ELISA
His-tagged bomapin was used for immunization of a rab-
bit and chicken. Total IgY were purified from egg yolk (all
at AgriSera AB, Sweden). This IgY and rabbit antiserum
were depleted from anti-his-tag antibodies on immobi-
lized his-tagged PAI-2 (serpinb2), and bomapin-specificPrzygodzka et al. BMC Cell Biology 2010, 11:30
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antibodies were purified on bomapin-NHS-Sepharose.
These antibodies were used for immunoprecipitation,
western blot, and ELISA. For ELISA, IgY (2 μg/ml) were
used for coating, and rabbit anti-bomapin antibodies (0.2
μg/ml) as first antibodies; these were followed by anti-
rabbit horseradish peroxidase-conjugated secondary
antibodies (Promega). The working range for the ELISA
was from 1 to 60 ng/ml. For immunostaining, the anti-
bodies were further pre-incubated with proteins from
K562 cell extract that were immobilized on NHS-Sephar-
ose.
Immunoprecipitation
The cells (2-5 × 108 cells) were lysed in 50 mM HEPES pH
7.4, 150 mM NaCl, 5% glycerol, 2.5 mM EDTA, 1% NP-40
and protease inhibitor cocktail (Roche Diagnostic). The
cell lysates were centrifuged, and then immunoprecipi-
tated with anti-bomapin IgY immobilized on NHS-Sep-
harose. The samples were analyzed by SDS-PAGE
followed by western blot. Bomapin was detected using
rabbit anti-bomapin antibodies, followed by anti-rabbit
horseradish peroxidase-conjugated secondary antibodies
(Promega). Immunoreactive bands were visualized with
the Enhanced Chemiluminescence Kit (ECL, GE Helth-
care).
Immunofluorescence microscopy of cells
Cells were seeded on poly-lysine coated cover slips
(Sigma), fixed in 3% paraformaldehyde, permeabilised
with 0.1% Triton X-100, and blocked with 2% goat serum
in PBS. Bomapin was stained with rabbit anti-bomapin
antibodies, followed by appropriate secondary antibodies
conjugated with Alexa Fluor 568 (Molecular Probes). In
the case of cells expressing bomapin-EGFP-fusion and
EGFP, fluorescence of EGFP was detected. Images were
captured with oil immersion using an AxioImager.Z1
m i c r o s c o p e  w i t h  A p o T o m e ,  l e n s e s  P L A N - A P O C H R O -
MAT 63 × 1.4, Axio Cam MRm (all from Zeiss) and Axio
Vision software version 4.5. For quantification of the
nuclear size, proliferating K562 cells expressing EGFP or
bomapin-EGFP were DAPI-stained, the images were cap-
tured, and the nuclear areas were measured using the
Axio Vision software.
Antisense oligonucleotides
U937 cells were incubated with antisense (BAS3: 5'-
GCCCTATACTTTAAAGGAATC-3') or sense (BS: 5'-
GCCCTATACTTTAAAGGAATC-3') phosphorothio-
ated DNA oligonucleotides (DNA Technology A/S, Den-
mark) at 20 nmol/ml, using standard growth conditions.
Cell proliferation was quantified by manual counting and
with Cell Proliferation Reagent WST-1. Bomapin expres-
sion was assessed by immunoprecipitation from equal
amounts of cell extracts (0.7 mg total protein) using anti-
bomapin IgY immobilized on NHS-Sepharose. This was
followed by western blot with bomapin-specific rabbit
antibodies. For loading control, a small amount of IgY
t h a t  n o r m a l l y  d e t a c h e s  f r o m  I g Y - S e p h a r o s e  d u r i n g  t h e
immunoprecipitation was detected with rabbit anti-
chicken antibodies coupled to alkaline peroxidase
(Sigma).
In silico models of reduced and oxidized bomapin
The model of reduced bomapin was generated from the
bomapin sequence (P48595) using the SWISS-MODEL
server (version 3.5) [29] with the coordinates of PAI-2
(1by7), serpinB1 (1hle), and ovalbumin (1ova) as tem-
plates. This model was energy-minimized further and
used to calculate the oxidized bomapin structure using
parallhdg.pro force field within X-PLOR version 3.851
[30]. To create the C68-C395 disulfide bond, residues
between positions 60-87 and 394-397 were allowed to
move freely under the simulated annealing [31] and simu-
lated annealing refinement protocols, whereas all other
residues were kept in fixed positions to preserve the sec-
ondary structure elements and the overall fold of
bomapin. The disulfide bond was introduced as a dis-
tance constraint (2.02 ± 0.05 Å) between the two sulphur
atoms of the cysteines. Altogether, 20 structures were cal-
culated and the structure with the lowest total energy was
chosen as being representative of the ensemble of struc-
tures. The models of reduced and oxidized bomapin have
been deposited to the Protein Model Data Base [32]http:/
/mi.caspur.it/PMDB/ with accession codes PM0074678
and PM0074679, respectively.
General methods
SDS-PAGE (10%) was performed as described previously
[33], and followed by Coomassie Blue staining or immu-
noblotting [34]. Protein concentration was determined
using the bicinchoninic acid assay (Pierce) or the Coo-
massie Plus Protein Reagent (Bio-Rad), with bovine
serum albumin as protein standard.
Statistical analysis
Data are expressed as mean values ± SEM, and analysed
for statistical significance using uncoupled t-student test
with confidence 95%; p value of <0.05 was considered as
significant.
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